These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 9247774

  • 1. High-dose torasemide, given once daily intravenously for one week, in patients with advanced chronic renal failure.
    Boesken WH, Kult J.
    Clin Nephrol; 1997 Jul; 48(1):22-8. PubMed ID: 9247774
    [Abstract] [Full Text] [Related]

  • 2. Single dose comparison of torasemide and furosemide in patients with advanced renal failure.
    Klütsch K, Grosswendt J, Haecker W.
    Arzneimittelforschung; 1988 Jan; 38(1A):200-4. PubMed ID: 3285834
    [Abstract] [Full Text] [Related]

  • 3. Comparison of efficacy and tolerance of different oral doses of torasemide and furosemide in patients with advanced chronic renal failure.
    Kult J, Häcker W, Glocke M.
    Arzneimittelforschung; 1988 Jan; 38(1A):212-4. PubMed ID: 3285837
    [Abstract] [Full Text] [Related]

  • 4. Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure.
    Fliser D, Schröter M, Neubeck M, Ritz E.
    Kidney Int; 1994 Aug; 46(2):482-8. PubMed ID: 7967362
    [Abstract] [Full Text] [Related]

  • 5. Torasemide in advanced renal failure.
    Kindler J.
    Cardiovasc Drugs Ther; 1993 Jan; 7 Suppl 1():75-80. PubMed ID: 8435381
    [Abstract] [Full Text] [Related]

  • 6. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R, Ciccarelli A, Ariano C, Cioppa C, Giasi A, Pucciarelli A, Cantatrione S.
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [Abstract] [Full Text] [Related]

  • 7. Renal excretory responses to single and repeated administration of diuretics in healthy subjects: clinical connotations.
    Reyes AJ, Leary WP.
    Cardiovasc Drugs Ther; 1993 Jan; 7 Suppl 1():29-44. PubMed ID: 8435375
    [Abstract] [Full Text] [Related]

  • 8. Dose-dependent salidiuretic efficacy of torasemide in comparison to furosemide and placebo in advanced renal failure.
    Mourad G, Haecker W, Mion C.
    Arzneimittelforschung; 1988 Jan; 38(1A):205-8. PubMed ID: 3285835
    [Abstract] [Full Text] [Related]

  • 9. A comparison of the pharmacokinetics and diuretic effects of two loop diuretics, torasemide and furosemide, in normal volunteers.
    Dodion L, Ambroes Y, Lameire N.
    Eur J Clin Pharmacol; 1986 Jan; 31 Suppl():21-7. PubMed ID: 3780837
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics and pharmacodynamics of torasemide in congestive heart failure.
    Kramer WG.
    Cardiology; 1994 Jan; 84 Suppl 2():108-14. PubMed ID: 7954532
    [Abstract] [Full Text] [Related]

  • 11. Diuretic activity of torasemide and furosemide in chronic heart failure: a comparative double blind cross-over study.
    Scheen AJ, Vancrombreucq JC, Delarge J, Luyckx AS.
    Eur J Clin Pharmacol; 1986 Jan; 31 Suppl():35-42. PubMed ID: 3780838
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics and pharmacodynamics of intravenous trasemide in mutant Nagase analbuminemic rats.
    Kim EJ, Lee MG.
    Biopharm Drug Dispos; 2003 Jan; 24(1):27-35. PubMed ID: 12516076
    [Abstract] [Full Text] [Related]

  • 13. Torasemide, a new loop diuretic, in patients with chronic renal failure.
    Russo D, Gazzotti RM, Testa A.
    Nephron; 1990 Jan; 55(2):141-5. PubMed ID: 2194134
    [Abstract] [Full Text] [Related]

  • 14. Torasemide. A review of its pharmacological properties and therapeutic potential.
    Friedel HA, Buckley MM.
    Drugs; 1991 Jan; 41(1):81-103. PubMed ID: 1706990
    [Abstract] [Full Text] [Related]

  • 15. Saluretic effect of the loop diuretic torasemide in chronic renal failure. Interdependence of electrolyte excretion.
    Knauf H, Mutschler E.
    Eur J Clin Pharmacol; 1990 Jan; 39(4):337-43. PubMed ID: 2076714
    [Abstract] [Full Text] [Related]

  • 16. Liver cirrhosis with ascites: pathogenesis of resistance to diuretics and long-term efficacy and safety of torasemide.
    Knauf H, Mutschler E.
    Cardiology; 1994 Jan; 84 Suppl 2():87-98. PubMed ID: 7954550
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Advantages of the new loop diuretic torasemide over furosemide in patients with cirrhosis and ascites. A randomized, double blind cross-over trial.
    Gerbes AL, Bertheau-Reitha U, Falkner C, Jüngst D, Paumgartner G.
    J Hepatol; 1993 Mar; 17(3):353-8. PubMed ID: 8315263
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.